4//SEC Filing
Leff Jonathan A 4
Accession 0001209191-12-032657
CIK 0001087432other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 6:57 PM ET
Size
9.0 KB
Accession
0001209191-12-032657
Insider Transaction Report
Form 4
INTERMUNE INCITMN
Leff Jonathan A
EVP of R&D
Transactions
- Award
Common Stock
2012-06-04$10.10/sh+2,000$20,200→ 77,200 total - Award
Stock Option (Right to Buy)
2012-06-04+10,000→ 10,000 totalExercise: $10.10Exp: 2022-06-03→ Common Stock (10,000 underlying) - Award
Common Stock
2012-06-04$10.10/sh+2,000$20,200→ 79,200 total
Footnotes (5)
- [F1]Reflects an award of restricted stock.
- [F2]Twenty-five percent (25%) of the shares subject to the restricted stock award shall become vested and releasable on each yearly anniversary of the grant date. Shares of common stock of the company issued upon completion of vesting of each installment of the restricted stock award will be delivered to the reporting person following the completion of vesting of the corresponding installment.
- [F3]Reflects a performance-based stock award.
- [F4]Shares will vest upon the successful completion of the ASCEND Phase 3 clinical study as determined by the Company's Board of Directors.
- [F5]Twenty-five percent (25%) of the total number of shares subject to the stock option vest and become exercisable on the first anniversary of the grant date. The remainder of the option shares vests and becomes exercisable cumulatively in equal monthly installments over the following thirty-six (36) months.
Documents
Issuer
INTERMUNE INC
CIK 0001087432
Entity typeother
Related Parties
1- filerCIK 0001469029
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 6:57 PM ET
- Size
- 9.0 KB